U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived

First Page		Document Content
Food and Drug Administration Combination drugs Respiratory therapy Asthma Amphetamines Formoterol Salmeterol Center for Drug Evaluation and Research Fluticasone/salmeterol Medicine Pharmacology Pulmonology		U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. This content has not been altered or updated since it was archived Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 275,44 KB Share Document on Facebook

	As at AugustAstraZeneca’s Environmental Risk Summaries As part of AstraZeneca’s ongoing commitment to environmental data transparency, this website provides environmental risk summaries for the Active Pharmace DocID: 1rlq4 - View Document
	Microsoft Word - Prosonix full abstract for DDL22_2_.doc DocID: 1rcKt - View Document
	Preferred Drug List Blue Cross complete DocID: 1pc13 - View Document
	Sunovion Pharmaceuticals Inc. 84 Waterford Drive, Marlborough, MATelNews Release Contact: DocID: 1pbCs - View Document
	Virginia Asthma Action Plan School Division: ________________________________________________________________________ Name Date of Birth DocID: 1oNoo - View Document